Begin with a 2.5 mg dose, gradually increasing every 4 weeks
Reta is provided strictly for research use only and is not intended for clinical or therapeutic applications
Topics include important information for 2024 on: Health Partners Plans Medicaid and CHIP, Jefferson Health Plans Medicare Advantage and Individual and Family Plans Lab and other benefit carriers Online tools (including provider portal website, etc.) Claim filing instructions and best practices Community HealthChoices program Maternity services Access and availability standards Pay-for-Performance and Quality Care Plus EPSDT standards Special HIV/AIDS services Member identification cards REGISTER TODAY To register, select the webinar you are interested in attending and click the registration link in the description
2 Significant glycemic and body weight reductions with tirzepatide treatments of 5, 10, or 15 mg once weekly have been consistently observed across a diverse T2DM population across several large clinical trials
Catts SV, Shelley AM, Ward PB, Liebert B, McConaghy N, Andrews S et al (1995)
